Follow Chr. Hansen A/S

Press Releases 3 hits

New partnership to develop treatment for peanut allergies

New partnership to develop treatment for peanut allergies

Press Releases   •   Apr 18, 2018 03:57 GMT

Prota Therapeutics, the developer of oral immunotherapies to treat food allergies, has partnered with Chr. Hansen. The partnership will assess the world’s best documented probiotic strain, LGG®, in a Phase III clinical trial to develop a treatment for peanut allergy.

To further strengthen its probiotics offering Chr. Hansen acquires LGG®, the world’s best documented probiotic strain, from Valio OY

To further strengthen its probiotics offering Chr. Hansen acquires LGG®, the world’s best documented probiotic strain, from Valio OY

Press Releases   •   Sep 13, 2016 06:02 GMT

Natural solutions that advance human health are in high demand and the expected growth for microbial solutions in this industry is 7-9%. Chr. Hansen is the world’s leading supplier of probiotics to dietary supplements, infant formula and dairy, and through the acquisition of the LGG® business, the company is now further strengthening its microbial platform across all three categories.

New study confirms presence of bifidobacteria and lactobacilli in breast milk from Chinese mothers

New study confirms presence of bifidobacteria and lactobacilli in breast milk from Chinese mothers

Press Releases   •   May 11, 2015 07:13 GMT

​A study initiated by Chr. Hansen has shown that bifidobacteria and lactobacilli are present in breast milk from Chinese mothers, strengthening the case for adding clinically documented probiotics to infant formula, in order to improve nutrition.

Images 2 hits

Chr. Hansen probiotics

Chr. Hansen probiotics

License Creative Commons Attribution
Photographer / Source Chr. Hansen
Download
Size

11.1 MB • 4872 x 6496 px

Infant formula

Infant formula

License Media Use
Download
Size

9.71 MB • 5760 x 3840 px